Resources

Results 901 - 925 of 1225

Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan [1]

The safety, efficacy, and quality of pharmaceutical products can be highly affected by the lack of adequate controls on importation. It is therefore imperative that the importation of pharmaceutical products conforms to certain set standards. In this context, the importation of pharmaceutical products should not be treated in the same way as ordinary commodities.

Technical Report: Waste Management of Pharmaceuticals in Afghanistan [3]

Afghanistan already has a pharmaceutical product waste disposal operation, and pharmaceutical materials are reviewed for disposal and destruction, but the current operation is generally believed to have many shortfalls. Attempts at estimating the scale of the issue using total throughput volumes of pharmaceuticals have indicated no major issue on waste disposal because not enough volume of ph

Afghanistan National Medicines Policy 2014-2019 [5]

The goals of this new edition of the National Medicines Policy are to ensure the continuous development of the pharmaceutical sector and to meet the health care pharmaceutical requirements of all people living in Afghanistan, through the provision and use of safe, efficacious, high quality, cost effective, and affordable medicines and related products.

SPS Afghanistan Leader with Associate: A Retrospective Report [7]

Building and strengthening health systems are difficult and take time.

SPS Afghanistan Associate Award Quarterly Newsletter [9]

Inside this issue: SPS Afghanistan Associate Award Stakeholders Update Pharmacy Curriculum National Food & Medicine Board Hosts Workshop Welcome from the Chief of Party SPS & GDPA Attend International Conference SPS Assists MoPH with Emergency Medicine Order Heath Communications Message Widely Broadcasted Transition of Drug Management Unit Completed

Adverse Drug Reaction Reporting and Management Assessment in Six Hospitals of Kabul, Afghanistan [11]

The Ministry of Public Health (MoPH), with technical and financial assistance of the Strengthening Pharmaceutical Systems (SPS) project funded by the US Agency for International Development (USAID), carried out the medicines safety assessment from March to August 2013 in six Kabul hospitals.

Pharmaceutical Logistic Information System (PLIS) Report on the Expansion Testing Phase in all BPHS/EPHS Implementing NGOs [13]

In Afghanistan, 20 non-governmental organizations are contracted by the Ministry of Public Health (MOPH) to provide support to the Basic Package for Health Services and Essential Package for Hospital Services (BPHS/EPHS) in all 34 provinces. The Pharmaceutical Logistics Information System (PLIS) was tested in all these NGOs in all the provinces in September 2013.

National Standard Treatment Guidelines for the Primary Level [15]

[16]

This national standard treatment guidelines (STGs) manual is designed for use at the first-level (i.e., primary) facilities delivering the Basic Package of Health Services (BPHS).

Functional Analysis of the General Directorate of Pharmaceutical Affairs [17]

The General Directorate of Pharmaceutical Affairs (GDPA) operates within the Ministry of Public Health (MOPH) in Afghanistan and is the prime body for managing pharmaceutical activities within the country in both the public and private sectors. MOPH recognizes the current difficulties on essential medicines and wishes to see a harmonized and integrated approach with a nationally coordinated m

Providing Technical Assistance to the National Medicine and Food Board in Afghanistan to Implement Food Regulations [19]

The National Medicine and Food Board (NMFB) was established in 2009, as an advisory board to the Ministry of Public Health (MOPH) to advise, coordinate, supervise, and accelerate medicines and food-related activities . . . “to ensure the safety and quality of food products and prevent their unnecessary and unsafe manufacture, importation, distribution, sale, and use”.

Situational Analysis of the Medicine Evaluation and Registration System of Afghanistan [21]

The pharmaceutical regulatory situation in Afghanistan is generally considered to be weak with most of the activities in the private sector and, to a l arge extent, in the public sector largely uncontrolled.

National Pharmaceutical Human Resources Strategic Framework 2013-2017 [23]

This framework seeks to outline a national strategy for the development of pharmaceutical HR in the public and private sectors in Afghanistan to produce a stronger pharmaceutical system that responds to the population’s needs.

Competency Framework for Pharmaceutical Services [24]

The pharmaceutical services competency framework defines competencies for core tasks in each area. Expert practitioners in each of the service areas identified the main tasks.

Afghanistan: CPDS, CSC, and ACSS Stakeholder Procurement, Distribution, and Quantification Activities and Functions Review [26]

For largely historical reasons of development in a post- or ongoing conflict situation, the current essential medicines supply mechanisms in Afghanistan are characterized by multiple funding sources and a large number of active players, giving rise to fragmented and, currently, largely uncoordinated service from multiple, vertical supply streams of varying efficiency. This is not to say that

Afghanistan Medicines Sampling and Testing - A Quantitative Survey [28]

The Afghanistan Ministry of Public Health (MoPH), with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program, carried out a survey of medicines quality in Afghanistan. The survey was conducted for the MoPH to determine whether medicines in the public and private sectors of Afghanistan comply with established international pharmacopeial standards.

Afghanistan Medicines Quality Assurance Assessment - A Qualitative Survey [30]

The Afghanistan Ministry of Public Health (MoPH) with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program carried out a qualitative survey of medicines quality assurance assessment in Afghanistan.

Strengthening regulatory system and structure for Medicines and Food Products in Afghanistan: The way forward [32]

The MoPH established the National Medicines and Food Board (NMFB) in 2009, as a multidisciplinary body to oversee and catalyze regulatory activities in medicines and food products.

Afghanistan Medicine Use Study: A Survey of 28 Health Facilities in 5 Provinces [33]

This medicine use study was planned, conducted, and analyzed by the Strengthening Pharmaceutical Systems (SPS) Program of Management Sciences for Health (MSH) in collaboration with the Ministry of Public Health (MoPH). Data collection for the study was conducted in March and April, 2009.

Assessment Report on Regulatory Framework and Structure for Medicines and Food in Afghanistan [35]

SPS conducted an initial assessment of the existing regulatory mechanisms and systems for food and medicinal products with the goal of proposing options and approaches for a well-developed regulatory framework. The assessment team interviewed 24 stakeholders related to food and medicine regulation (7 food-specific, 6 medicines-specific, and 11 related to both).

Coordinated Procurement and Distribution System (CPDS) Governance Framework [36]

An uninterrupted supply of pharmaceutical products is required to ensure the provision of clinical services according to the Basic Package of Health Services (BPHS) and the Essential Package of Hospital Services (EPHS).

Afghanistan Technical Report: Interim Findings and Conclusions of Drug Financing [38]

During the course of its work in Afghanistan, the SPS program has identified multiple challenges confronting the pharmaceutical system in Afghanistan that combine to limit the access to quality pharmaceuticals by the Afghan population.

Technical Report: Implementation of GPHF-Minilab Pilot in Afghanistan [40]

One of the biggest challenges developing countries face in their fight against counterfeit and substandard medicines is building their technical capacity to regulate medicines. Without effective and affordable analytical technologies, the quality of the medicines cannot be secured in the country.

Mapping the Pharmacy Assistant Curriculum Against the Competency Framework for Pharmaceutical Services in Afghanistan [42]

The objective of the curriculum mapping activity was to map the current pharmacy assistant curricula in the GIHS and one private Pharmacy school against the Competency Framework for Pharmaceutical Services to identify strengths and gaps in the current curriculum, and make recommendations for improvement.

Surgical Antibiotic Prophylaxis Standard Treatment Guidelines [44]

The Nangarhar Public Health Directorate, the HealthNet Trans Psychosocial Organization (HN TPO), and the USAID-funded Strengthening Pharmaceutical Systems (SPS) Program implemented by Management Sciences for Health (MSH) are pleased to present the 2013 edition of the Surgical Antibiotic Prophylaxis Standard Treatment Guidelines.

Dental and Orofacial Diseases Standard Treatment Guideline [46]

It is a delightful opportunity for the Stomatology hospital DTC Committee and the management team to be able to be engaged in the development of stomatology standard therapeutic Guidelines.

Pages

Links
[1] https://www.msh.org/resources/foreign-pharmaceutical-manufacturing-company-registration-guideline-for-afghanistan?page=36
[2] https://www.msh.org/resources/foreign-pharmaceutical-manufacturing-company-registration-guideline-for-afghanistan
[3] https://www.msh.org/resources/technical-report-waste-management-of-pharmaceuticals-in-afghanistan?page=36
[4] https://www.msh.org/resources/technical-report-waste-management-of-pharmaceuticals-in-afghanistan
[5] https://www.msh.org/resources/afghanistan-national-medicines-policy-2014-2019?page=36
[6] https://www.msh.org/resources/afghanistan-national-medicines-policy-2014-2019
[7] https://www.msh.org/resources/sps-afghanistan-leader-with-associate-a-retrospective-report?page=36
[8] https://www.msh.org/resources/sps-afghanistan-leader-with-associate-a-retrospective-report
[9] https://www.msh.org/resources/sps-afghanistan-associate-award-quarterly-newsletter?page=36
[10] https://www.msh.org/resources/sps-afghanistan-associate-award-quarterly-newsletter
[11] https://www.msh.org/resources/adverse-drug-reaction-reporting-and-management-assessment-in-six-hospitals-of-kabul?page=36
[12] https://www.msh.org/resources/adverse-drug-reaction-reporting-and-management-assessment-in-six-hospitals-of-kabul
[13] https://www.msh.org/resources/pharmaceutical-logistic-information-system-plis-report-on-the-expansion-testing-phase-in?page=36
[14] https://www.msh.org/resources/pharmaceutical-logistic-information-system-plis-report-on-the-expansion-testing-phase-in
[15] https://www.msh.org/resources/national-standard-treatment-guidelines-for-the-primary-level?page=36
[16] https://www.msh.org/resources/national-standard-treatment-guidelines-for-the-primary-level
[17] https://www.msh.org/resources/functional-analysis-of-the-general-directorate-of-pharmaceutical-affairs?page=36
[18] https://www.msh.org/resources/functional-analysis-of-the-general-directorate-of-pharmaceutical-affairs
[19] https://www.msh.org/resources/providing-technical-assistance-to-the-national-medicine-and-food-board-in-afghanistan-to?page=36
[20] https://www.msh.org/resources/providing-technical-assistance-to-the-national-medicine-and-food-board-in-afghanistan-to
[21] https://www.msh.org/resources/situational-analysis-of-the-medicine-evaluation-and-registration-system-of-afghanistan?page=36
[22] https://www.msh.org/resources/situational-analysis-of-the-medicine-evaluation-and-registration-system-of-afghanistan
[23] https://www.msh.org/resources/national-pharmaceutical-human-resources-strategic-framework-2013-2017?page=36
[24] https://www.msh.org/resources/competency-framework-for-pharmaceutical-services?page=36
[25] https://www.msh.org/resources/competency-framework-for-pharmaceutical-services
[26] https://www.msh.org/resources/afghanistan-cpds-csc-and-acss-stakeholder-procurement-distribution-and-quantification?page=36
[27] https://www.msh.org/resources/afghanistan-cpds-csc-and-acss-stakeholder-procurement-distribution-and-quantification
[28] https://www.msh.org/resources/afghanistan-medicines-sampling-and-testing-a-quantitative-survey?page=36
[29] https://www.msh.org/resources/afghanistan-medicines-sampling-and-testing-a-quantitative-survey
[30] https://www.msh.org/resources/afghanistan-medicines-quality-assurance-assessment-a-qualitative-survey?page=36
[31] https://www.msh.org/resources/afghanistan-medicines-quality-assurance-assessment-a-qualitative-survey
[32] https://www.msh.org/resources/strengthening-regulatory-system-and-structure-for-medicines-and-food-products-in?page=36
[33] https://www.msh.org/resources/afghanistan-medicine-use-study-a-survey-of-28-health-facilities-in-5-provinces?page=36
[34] https://www.msh.org/resources/afghanistan-medicine-use-study-a-survey-of-28-health-facilities-in-5-provinces
[35] https://www.msh.org/resources/assessment-report-on-regulatory-framework-and-structure-for-medicines-and-food-in?page=36
[36] https://www.msh.org/resources/coordinated-procurement-and-distribution-system-cpds-governance-framework?page=36
[37] https://www.msh.org/resources/coordinated-procurement-and-distribution-system-cpds-governance-framework
[38] https://www.msh.org/resources/afghanistan-technical-report-interim-findings-and-conclusions-of-drug-financing?page=36
[39] https://www.msh.org/resources/afghanistan-technical-report-interim-findings-and-conclusions-of-drug-financing
[40] https://www.msh.org/resources/technical-report-implementation-of-gphf-minilab-pilot-in-afghanistan?page=36
[41] https://www.msh.org/resources/technical-report-implementation-of-gphf-minilab-pilot-in-afghanistan
[42] https://www.msh.org/resources/mapping-the-pharmacy-assistant-curriculum-against-the-competency-framework-for?page=36
[43] https://www.msh.org/resources/mapping-the-pharmacy-assistant-curriculum-against-the-competency-framework-for
[44] https://www.msh.org/resources/surgical-antibiotic-prophylaxis-standard-treatment-guidelines?page=36
[45] https://www.msh.org/resources/surgical-antibiotic-prophylaxis-standard-treatment-guidelines
[46] https://www.msh.org/resources/dental-and-orofacial-diseases-standard-treatment-guideline?page=36
[47] https://www.msh.org/resources/dental-and-orofacial-diseases-standard-treatment-guideline
[48] https://www.msh.org/resources
[49] https://www.msh.org/resources?page=35
[50] https://www.msh.org/resources?page=32
[51] https://www.msh.org/resources?page=33
[52] https://www.msh.org/resources?page=34
[53] https://www.msh.org/resources?page=37
[54] https://www.msh.org/resources?page=38
[55] https://www.msh.org/resources?page=39
[56] https://www.msh.org/resources?page=40
[57] https://www.msh.org/resources?page=48